Griffin Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,955
Closed -$1.19M 242
2019
Q3
$1.19M Sell
11,955
-1,735
-13% -$165K 0.18% 105
2019
Q2
$1.27M Sell
13,690
-2,650
-16% -$252K 0.16% 118
2019
Q1
$1.54M Sell
16,340
-225
-1% -$19.7K 0.22% 106
2018
Q4
$1.06M Buy
16,565
+1,120
+7% +$82.7K 0.18% 122
2018
Q3
$1.38M Buy
15,445
+5,230
+51% +$462K 0.2% 117
2018
Q2
$811K Sell
10,215
-165
-2% -$13.7K 0.15% 133
2018
Q1
$926K Buy
10,380
+100
+1% +$9.6K 0.17% 129
2017
Q4
$1.07M Sell
10,280
-890
-8% -$100K 0.19% 126
2017
Q3
$1.63M Buy
+11,170
New +$1.52M 0.29% 92

Other funds holding CELG

Griffin Asset Management's CELG Position: Q4 2019 in Review

Griffin Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,955 shares — an estimated $1.19M sold.

Griffin Asset Management first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $1.63M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Griffin Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Griffin Asset Management sold 11,955 Celgene Corp shares in Q4 2019, an estimated $1.19M.
  • Griffin Asset Management first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Griffin Asset Management's Celgene Corp position peaked at $1.63M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Griffin Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.